Survodutide
A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver
Boehringer Ingelheim · Phase 1 · Active, not recruiting · Enrollment 29
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Group 1: BI 456906 | Obesity or overweight | n/r | 17 | n/r | n/r |
| Group 2: Semaglutide | Obesity or overweight | n/r | 17 | n/r | n/r |
| Group 3: BI 456906 | Obesity or overweight | n/r | 17 | n/r | n/r |
| Group 4: Semaglutide | Obesity or overweight | n/r | 17 | n/r | n/r |